News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,466 Results
Type
Article (55839)
Company Profile (341)
Press Release (705286)
Section
Business (218498)
Career Advice (2892)
Deals (37475)
Drug Delivery (120)
Drug Development (86324)
Employer Resources (187)
FDA (17268)
Job Trends (16025)
News (370119)
Policy (35725)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (6)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2931)
Academic (1)
Accelerated approval (4)
Adcomms (27)
Allergies (87)
Alliances (53939)
ALS (92)
Alzheimer's disease (1463)
Antibody-drug conjugate (ADC) (134)
Approvals (17241)
Artificial intelligence (272)
Autoimmune disease (18)
Automation (14)
Bankruptcy (388)
Best Places to Work (12296)
BIOSECURE Act (20)
Biosimilars (111)
Biotechnology (242)
Bladder cancer (65)
Brain cancer (28)
Breast cancer (268)
Cancer (2132)
Cardiovascular disease (181)
Career advice (2426)
Career pathing (32)
CAR-T (155)
Cell therapy (433)
Cervical cancer (20)
Clinical research (69644)
Collaboration (832)
Compensation (473)
Complete response letters (26)
COVID-19 (2811)
CRISPR (42)
C-suite (229)
Cystic fibrosis (103)
Data (2030)
Decentralized trials (2)
Denatured (29)
Depression (48)
Diabetes (266)
Diagnostics (6769)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (115)
Drug shortages (30)
Duchenne muscular dystrophy (93)
Earnings (89099)
Editorial (39)
Employer branding (24)
Employer resources (160)
Events (120603)
Executive appointments (691)
FDA (18441)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (738)
Gene editing (109)
Generative AI (26)
Gene therapy (316)
GLP-1 (785)
Government (4863)
Grass and pollen (5)
Guidances (49)
Healthcare (20325)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (27)
Infectious disease (2956)
Inflammatory bowel disease (145)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (90)
Interviews (558)
IPO (17098)
IRA (48)
Job creations (4181)
Job search strategy (2006)
Kidney cancer (10)
Labor market (34)
Layoffs (511)
Leadership (20)
Legal (8806)
Liver cancer (76)
Lung cancer (313)
Lymphoma (137)
Machine learning (4)
Management (64)
Manufacturing (292)
MASH (68)
Medical device (14278)
Medtech (14283)
Mergers & acquisitions (20857)
Metabolic disorders (698)
Multiple sclerosis (78)
NASH (23)
Neurodegenerative disease (99)
Neuropsychiatric disorders (29)
Neuroscience (2001)
NextGen: Class of 2025 (7246)
Non-profit (4917)
Northern California (2508)
Now hiring (37)
Obesity (377)
Opinion (252)
Ovarian cancer (74)
Pain (88)
Pancreatic cancer (79)
Parkinson's disease (147)
Partnered (20)
Patents (219)
Patient recruitment (100)
Peanut (51)
People (62395)
Pharmaceutical (74)
Pharmacy benefit managers (19)
Phase I (21687)
Phase II (30538)
Phase III (22816)
Pipeline (1093)
Podcasts (91)
Policy (134)
Postmarket research (2927)
Preclinical (9327)
Press Release (72)
Prostate cancer (96)
Psychedelics (38)
Radiopharmaceuticals (265)
Rare diseases (393)
Real estate (6552)
Recruiting (72)
Regulatory (24177)
Reports (47)
Research institute (2584)
Resumes & cover letters (457)
Rett syndrome (4)
RNA editing (4)
RSV (44)
Schizophrenia (75)
Series A (130)
Series B (83)
Service/supplier (16)
Sickle cell disease (57)
Southern California (2171)
Special edition (16)
Spinal muscular atrophy (160)
Sponsored (31)
Startups (3967)
State (2)
Stomach cancer (16)
Supply chain (65)
Tariffs (14)
The Weekly (60)
United States (22230)
Vaccines (748)
Venture capitalists (39)
Webinars (13)
Weight loss (267)
Women's health (34)
Worklife (18)
Date
Today (61)
Last 7 days (701)
Last 30 days (2719)
Last 365 days (35096)
2025 (8742)
2024 (37036)
2023 (41973)
2022 (53248)
2021 (57941)
2020 (56833)
2019 (50179)
2018 (38009)
2017 (34941)
2016 (34936)
2015 (41142)
2014 (35117)
2013 (30532)
2012 (32657)
2011 (33113)
2010 (31317)
Location
Africa (935)
Alabama (50)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (43327)
Australia (7830)
California (5746)
Canada (1910)
China (504)
Colorado (257)
Connecticut (269)
Delaware (136)
Europe (96765)
Florida (842)
Georgia (208)
Idaho (62)
Illinois (545)
India (25)
Indiana (303)
Iowa (9)
Japan (147)
Kansas (105)
Kentucky (25)
Louisiana (10)
Maine (61)
Maryland (876)
Massachusetts (4400)
Michigan (232)
Minnesota (393)
Mississippi (2)
Missouri (83)
Montana (31)
Nebraska (25)
Nevada (57)
New Hampshire (68)
New Jersey (1646)
New Mexico (30)
New York (1646)
North Carolina (1017)
North Dakota (8)
Northern California (2508)
Ohio (199)
Oklahoma (15)
Oregon (38)
Pennsylvania (1294)
Puerto Rico (10)
Rhode Island (29)
South America (1321)
South Carolina (18)
South Dakota (1)
Southern California (2171)
Tennessee (98)
Texas (856)
Utah (173)
Virginia (138)
Washington D.C. (62)
Washington State (543)
West Virginia (3)
Wisconsin (52)
761,466 Results for "biostage inc formerly known as harvard apparatus regenerative technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.
May 13, 2024
·
6 min read
Genetown
Biostage, Inc. Changes Name to Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN)
Biostage, Inc. (OTCQB: formerly BSTG) announced today it has changed its corporate name back to Harvard Apparatus Regenerative Technology, Inc. and trade under the OTCQB symbol “HRGN” effective July 20, 2023.
July 20, 2023
·
4 min read
Business
Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported fourth quarter and full year 2023 financial results.
April 2, 2024
·
9 min read
Press Releases
Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors
August 28, 2024
·
4 min read
Genetown
Harvard Apparatus Regenerative Technology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Establish a Research Collaboration to Study the Repair and Regeneration of the Colon following Colectomy
Harvard Apparatus Regenerative Technology, Inc. announced that it officially executed a sponsored research agreement with Drs. Stephen Badylak, George Hussey and Vincent Anto at the McGowan Institute for Regenerative Medicine, a center of the University of Pittsburgh and UPMC focused on developing regenerative therapies to address organ and tissue failure.
December 18, 2023
·
6 min read
Press Releases
Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children’s Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia
October 28, 2024
·
5 min read
Genetown
Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q3 2023 Results
Harvard Apparatus Regenerative Technology, Inc. announced that it will release Q3 2023 financial results on November 13, 2023 and host a conference call and webcast on the same day November 13, 2023 at 9:00 AM ET to discuss financial results and business updates for the third-quarter 2023.
November 9, 2023
·
4 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
March 13, 2025
·
1 min read
Press Releases
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
March 6, 2025
·
4 min read
1 of 76,147
Next
